Anti-TNFs.

Bibliographic Details
Published in:Gastroenterology & Hepatology Vol. 18; pp. 4 - 5
Main Author: Lichtenstein, Gary R.
Format: tables/charts Journal Article
Published: Gastro-Hep Communications, Inc 2022 Supplement
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=161114364&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 161114364
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15547914
        6N5B
      jtl: Gastroenterology & Hepatology
      issn: 15547914
      maglogo: N
    pubinfo:
      dt: 2022 Supplement
      vid: 18
      pid: 72163
      pub: Gastro-Hep Communications, Inc
      place: New York, New York
    artinfo:
      ui:
        161114364
        161114364
        161114364
        161114364
      ppf: 4
      ppct: 1
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Anti-TNFs.
      aug:
        au: Lichtenstein, Gary R.
        affil: Professor of Medicine, Director, Center for Inflammatory Bowel Disease, University of Pennsylvania Health System, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
      sug:
        subj:
          Tumor Necrosis Factor Inhibitors Therapeutic Use
          Colitis, Ulcerative Drug Therapy
          Crohn Disease Drug Therapy
          Infliximab Therapeutic Use
          Drug Efficacy
          Biological Markers
          Disease Remission
          Recurrence Prevention and Control
          C-Reactive Protein Blood
          Antigens, Surface Analysis
      pubtype: Academic Journal
      doctype:
        tables/charts
        Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N